
Pfizer, BioNTech Lose Appeal in COVID–19 Vaccine Patent Battle With Moderna
The London Court of Appeal upheld an earlier court decision in the long–running battle between the global pharma firms.

The London Court of Appeal upheld an earlier court decision in the long–running battle between the global pharma firms.

The ECJ’s landmark ruling isn’t about vaccines or corruption; it’s a battle for democracy against an elite determined to hide the truth and protect its power.

EU countries blame Brussels for purchasing excessive doses at a high cost.

Results of the study demonstrated the lack of justification for pushing the Comirnaty COVID-19 vaccine, whether through propaganda, social pressure, or mandates.

There is something shady about the EU’s new deal with Pfizer. Albeit at a higher price, EU countries will have to pay for fewer COVID-19 vaccine doses, but the Commission refuses to say exactly how many.

Speakers did not rule out the possibility that the pandemic was orchestrated by powerful outside actors, with various medical professionals from across Europe describing their first-hand experiences of negative health effects from vaccines.

The excess of vaccines procured and the exorbitant amount of money involved in the deal have many officials across the EU asking questions.

The Lancet decided not to publish the letter, calling their assessment “misinformation” and denying that one of the study’s authors had a conflict of interest.

It is “irrational” to buy more vaccines, Bulgaria argued, as it prepares to destroy more vaccines, now expired, than it had administered.

A cross-partisan group of MEPs assembled to criticise the potential sabotage of the EU’s committee charged with examining the bloc’s COVID response, with Italian MEP Francesca Donato accusing Green groups of bowing down to corporate power.